Articles tagged "Hepatitis B"

2021 American Transplant Congress
Use of Hepatitis B N.A.T. Positive Kidneys in Hepatitis B Immune Recipients
E. Stephenson¹, B. Nangunuri², T. McCune³
¹Nephrology and Critical Care, Eastern Virginia Medical School, Norfolk, VA, ²Eastern Virginia Medical School, Norfolk, VA, ³Nephrology, Eastern Virginia Medical School, Norfolk, VA
*Purpose: There is an increasing demand for kidney donations as roughly 4000 people die on the waitlist each year while the number of kidneys being…
2021 American Transplant Congress
Impact of Non-active Hepatitis B on Patient Survival After Renal Transplantation
A. Paschereit¹, K. Budde², M. Duerr², M. G. Naik²
¹Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité University Medicine Berlin, Berlin, Germany, ²Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Dialysis patients (pts) have an increased risk for hepatitis B (HB) infection and impaired response to HB vaccine compared to the general population. As…
2021 American Transplant Congress
De Novo Hepatitis B Infection Following Liver Transplant with Hepatitis B Core Antibody Positive Graft
L. J. Myhre¹, K. D. Watt², B. A. Aqel³
¹Pharmacy, Mayo Clinic, Rochester, MN, ²Gastroenterology/Hepatology, Mayo Clinic, Rochester, MN, ³Gastroenterology/Hepatology, Mayo Clinic, Phoenix, AZ
*Purpose: The risk of de novo HBV infection in liver transplant recipients of Hepatitis B core antibody (HBcAb) positive donor organs is tempered by availability…
2020 American Transplant Congress
Effects of Tenofovir and Entecavir on Glomerular Kidney Function in Liver Transplant Patients: A Nationwide Cohort Study
J. Lee¹, E. Kim¹, S. Yang¹, S. Kim¹, J. Lee¹, J. Park², H. Choi³, B. Kim², D. Joo¹, S. Kim¹, M. Kim¹
¹Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, ²Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, ³Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of
*Purpose: Entecavir and tenofovir are currently the first-line drugs in liver transplantation (LT) patients for the prevention of hepatitis B virus recurrence. Despite its proven…
2020 American Transplant Congress
Renal Safety of Entecavir and Tenofovir with Hepatitis B Immunoglobulin in Liver Transplant Patients
J. Lee¹, E. Kim¹, S. Yang¹, D. Kim², S. Kim¹, J. Park³, H. Choi⁴, B. Kim³, D. Joo¹, M. Kim¹, S. Kim¹, J. Lee¹
¹Department of Transplantation Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ²Department of Surgery, Wonju Severance Hospital, Yonsei University College of Medicine, Wonju, Korea, Republic of, ³Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of, ⁴Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Combination of potent nucleos(t)ide analougues (NAs) and hepatitis B immunoglobulin is recommended after liver transplantation for the prevention of hepatitis B virus (HBV) recurrence.…
2020 American Transplant Congress
Impact of Non-Active Hepatitis B after Renal Transplantation
M. G. Naik, W. Duettmann, M. Mayrdorfer, F. Halleck, K. Budde, M. Duerr
Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Hepatitis B (HB) is more frequent in dialysis patients (pts) than in the general population. Patient and graft survival in pts with chronic HB…
2020 American Transplant Congress
Kidney Transplantation from HBsAg+ Living Donors to HBsAg- Recipients: A Propensity Score-Matched Study at a High-Volume Center in China
X. Wang, J. Liu, T. Song, Y. Fan, Z. Huang, T. Lin
Urology, West China Hospital, Chengdu, China
*Purpose: Data on kidney transplantation (KTx) from hepatitis B surface antigen (HBsAg)+ donors to HBsAg- recipients [D(HBsAg+)/R(HBsAg-)] are limited. We aimed to report the outcomes…
2020 American Transplant Congress
Hepatitis B Virus Prophylaxis and Treatment among Hematopoietic Stem Cell Transplant Recipients: Impact on Engraftment and Outcomes
B. Buzo¹, J. Fernandes Ramos², R. Marques Rossetti³, N. Salles⁴, A. Mendrone-Junior⁴, V. Rocha³, A. de Seixas Santos Nastri⁵
¹Division of Infectious Diseases, University of Alberta, Edmonton, AB, Canada, ²Division of Infectious Diseases and Division of Hematology, University of Sao Paulo, Sao Paulo, Brazil, ³Division of Hematology, University of Sao Paulo, Sao Paulo, Brazil, ⁴Fundacao Pro-Sangue, Sao Paulo, Brazil, ⁵Division of Infectious Diseases, University of Sao Paulo, Sao Paulo, Brazil
*Purpose: Hepatitis B virus infection is a worldwide concern with a broad distribution. It can reactivate in immunocompromised populations such as solid organ and hematopoietic…
2020 American Transplant Congress
Pharmacist Initiated Hepatitis B Vaccinations in Liver Transplant Recipients
A. Reid¹, S. Todd¹, M. Morrison², A. Adams¹
¹Emory University Hospital, Atlanta, GA, ²Vanderbilt University Medical Center, Nashville, TN
*Purpose: The risk of developing hepatitis B after liver transplantation remains high in nonimmune patients receiving an allograft from a hepatitis B core antibody positive…
2020 American Transplant Congress
Outcome after Kidney Transplantation in Hepatitis Surface Antigen-Positive Patients
H. Mo, S. Min, H. Ko, C. Chung, H. Kim, A. Han, J. Ha
Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Because of the low prevalence of Hepatitis Surface Antigen (HBsAg)-positive patients, only a few reports have evaluated the actual outcome of these patients after…

1
2
3
…
6
Next Page »